COMMUNIQUÉS West-GlobeNewswire

Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025
23/07/2025
WESTLAKE VILLAGE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
23/07/2025
Appointments of new CEO, CFO, and seasoned business development leaders with proven track records of executing strategic transactions will position the Company to drive shareholder value and advance pipeline expansion [...]
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors
23/07/2025
New Directors bring deep commercial, operational, and transaction experience to the Board Mechelen, Belgium; July 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointments by way [...]
Muscle Building Supplements 2025: CrazyBulk Introduces Effective Bodybuilding Supplements For Muscle Growth, Bulking, Cutting And Strength in USA
23/07/2025
Muscle Building Supplements: A Game-Changer in Strength Training Programs New York City, NY, July 23, 2025 (GLOBE NEWSWIRE) -- When it comes to enhancing muscle mass, strength, and performance, supplements have become [...]
Valley Hemp Introduces THCa Flower Wholesale Guide for 2025 Hemp Market Growth
23/07/2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- With consumers increasingly turning to natural wellness products, THCa flower has become one of the most discussed hemp options on the market. In response to this growing [...]
Healthcare Heroes PLLC is launching a nationwide wellness certification initiative.
23/07/2025
Healthcare Heroes PLLC Launches National Wellness Certification to Transform U.S. Healthcare Culture FRISCO, TX, July 23, 2025 (GLOBE NEWSWIRE) -- Healthcare Heroes PLLC , a wellness-focused organization based in Texas [...]
Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025
23/07/2025
DUBLIN and BRIDGEWATER, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s [...]
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
23/07/2025
Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the "Company" or "ProPhase") [...]
Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product
23/07/2025
An Orphan Drug Designation Could Provide Significant Benefits to Regen SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provides further insight into its planned Phase [...]
PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills
23/07/2025
PetMeds and myBalto Host “Top of the Class” Drive to Provide Care for Pets Who Need It Most DELRAY BEACH, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds ® ”) (NASDAQ: PETS) today announced that [...]
Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindness
23/07/2025
Collaboration aims to accelerate development of OPGx-RDH12, a gene therapy for RDH12-associated Leber congenital amaurosis (RDH12-LCA) RESEARCH TRIANGLE PARK, N.C., July 23, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc [...]
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs
23/07/2025
During the year ended April 30, 2025, net cash provided by financing activities was $10.4 million Stockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cash In May 2025, Alzamend dosed the [...]
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib
23/07/2025
Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and [...]
Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
23/07/2025
- SGT-501 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations - - Potential first-in-class therapy with FDA IND clearance and Health Canada CTA approval designed to address underlying [...]
Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025
23/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage Pharma ” or the “ Company ”), a global biopharmaceutical company dedicated [...]
Respiree Closes US$11.6M Series A Financing Round Led by We Venture Capital and ClavystBio
23/07/2025
HOUSTON and SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- Respiree , a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, announced the [...]
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress
23/07/2025
– 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D- [...]
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
23/07/2025
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology [...]
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference
23/07/2025
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have [...]

Pages